NBA-1901
Fibrosis
PreclinicalActive
Key Facts
About NB Health Laboratory
Japanese biotech developing GPCR-targeted antibodies using its proprietary MoGRAA® Discovery Engine platform.
View full company profileTherapeutic Areas
Other Fibrosis Drugs
| Drug | Company | Phase |
|---|---|---|
| Lead Fibrosis Program | Nosis Bio | Preclinical |
| Liver Fibrosis Assay | TissueVision | Preclinical |
| OST-664 | Oncostellae | Discovery |
| Undisclosed second mAb | NB Health Laboratory | Preclinical |